DENTALI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 24.273
EU - Europa 13.253
AS - Asia 2.988
Continente sconosciuto - Info sul continente non disponibili 33
SA - Sud America 27
OC - Oceania 8
AF - Africa 5
Totale 40.587
Nazione #
US - Stati Uniti d'America 24.245
IT - Italia 6.688
UA - Ucraina 2.279
TR - Turchia 1.607
SE - Svezia 1.187
IE - Irlanda 898
DE - Germania 749
VN - Vietnam 731
CN - Cina 559
FI - Finlandia 501
GB - Regno Unito 475
FR - Francia 196
BE - Belgio 145
RU - Federazione Russa 46
IN - India 43
EU - Europa 29
CA - Canada 24
NL - Olanda 23
JP - Giappone 13
BR - Brasile 12
CL - Cile 11
ES - Italia 9
PT - Portogallo 8
AU - Australia 7
RO - Romania 7
CH - Svizzera 6
GR - Grecia 6
AT - Austria 5
HU - Ungheria 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AR - Argentina 3
EG - Egitto 3
HK - Hong Kong 3
ID - Indonesia 3
IL - Israele 3
IR - Iran 3
MY - Malesia 3
NO - Norvegia 3
SG - Singapore 3
DK - Danimarca 2
HN - Honduras 2
KR - Corea 2
LI - Liechtenstein 2
PL - Polonia 2
RS - Serbia 2
SI - Slovenia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 40.587
Città #
Milan 4.989
Fairfield 4.108
Woodbridge 2.671
Ashburn 2.017
Houston 1.922
Jacksonville 1.808
Seattle 1.604
Wilmington 1.492
Chandler 1.390
Cambridge 1.384
Ann Arbor 1.312
Dublin 893
Izmir 813
Princeton 788
Dearborn 591
Nyköping 540
Dong Ket 367
Rome 313
San Diego 243
San Mateo 159
Ogden 152
Brussels 140
Beijing 127
London 118
Como 112
Washington 103
New York 72
Düsseldorf 70
Hefei 62
Redmond 62
Nanjing 59
Philadelphia 54
Helsinki 53
Norwalk 53
Kunming 50
Verona 48
Kocaeli 39
Paris 39
Kilburn 30
Jinan 29
Frankfurt am Main 24
Nanchang 24
Prescot 24
Boardman 22
Besana In Brianza 20
Chiswick 20
Falls Church 19
Ponte Lambro 19
Redwood City 19
Boydton 18
Guangzhou 18
Acton 17
Fuzhou 17
Chicago 16
Hounslow 16
Toronto 16
Indiana 14
Shenyang 14
Varese 14
Berlin 13
New Bedfont 13
Bergamo 12
Islington 12
Tokyo 11
Wandsworth 11
Hebei 10
Los Angeles 10
San Francisco 10
Southwark 10
Wuhan 10
Xian 10
Changsha 9
Dallas 9
Hanover 9
Pune 9
Phoenix 8
Ralingen 8
Suresnes 8
São Paulo 8
Zhengzhou 8
Chongqing 7
Ningbo 7
Torino 7
Abbiategrasso 6
Detroit 6
Hangzhou 6
Legnano 6
Magnago 6
Saint Louis 6
Amsterdam 5
Andover 5
Baotou 5
Busto Arsizio 5
Cleveland 5
Novara 5
Parma 5
Quzhou 5
Shaoxing 5
Auburn Hills 4
Bangkok 4
Totale 31.545
Nome #
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis 233
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery 224
Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature 221
Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency vka anticoagulation reversal 217
Risk of recurrence of unusual site venous thromboembolism 214
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 196
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis 196
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome 192
Optimal treatment duration of venous thrombosis 189
incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio. 187
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature 187
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry 186
Patient selection for thromboprophylaxis in medical inpatients 185
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis. 182
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice 179
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable? 178
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature 178
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study 178
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism. 177
Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis 176
Venous ischemic syndromes 175
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data 174
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis 173
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study 171
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation 170
Warfarin interactions with antibiotics in the ambulatory care setting 169
Duration of anticoagulation after venous thromboembolism in real world clinical practice 169
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism 168
Venous and arterial thrombosis in patients with HIV infection 166
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens 166
Seasonal and monthly variation in occurrence of hypertensive urgency 165
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis 164
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation 163
Statins and secondary prevention of ischemic and hemorrhagic stroke 162
Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis 161
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature 161
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study 161
Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation. 161
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study 160
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature 160
Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians 159
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding 158
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism 158
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment 157
ABO blood group and vascular disease: an update 157
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy 157
Low-molecular -weight heparin in pregnancies after ART -A retrospective study- 156
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree? 155
Is diabetes a hypercoagulable state? A critical appraisal 155
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage 154
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action. 154
In vitro effects of Apixaban on 5 different cancer cell lines 154
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension. 153
The role of inherited thrombophilia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature 153
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: A multicenter retrospective cohort study 153
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs 153
sRAGE and early signs of cardiac target organ damage in mild hypertensives 152
Prevention of in-hospital VTE: why can't we do better? 151
The role of thrombolytic therapy in pulmonary embolism 151
Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events 151
Statins for acute ischemic stroke 150
How I treat splanchnic vein thrombosis 149
The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis. 147
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal 147
Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism: Comment 147
The effect of thyroid autoantibodies on warfarin stability 147
Italian intersociety consensus on DOAC use in internal medicine 147
Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE Study 146
In-hospital mortality due to pulmonary embolism in patients with Alzheimer disease: A sex effect? 146
Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience 145
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes 144
Direct oral anticoagulants for superficial-vein thrombosis 144
Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: Results of a patient-level meta-analysis 143
The prevention and treatment of venous thromboembolism in pregnancy 143
Management of hypertension in overweight and obese patients: a practical guide for clinicians. 142
Clinical Pregnancies and Live Births in women approaching ART: a follow-up analysis of 157 women after thrombophilia screening 142
Antithrombin levels and the risk of a first episode of venous thromboembolism: a case-control study 142
Neutrophil-to-lymphocyte ratio: A new prognostic factor even in patients with heart failure 142
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism. 141
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases 141
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy 141
A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. 140
Inferior vena cava filter in patients with venous thromboembolism and major bleeding events: building the evidence 140
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study 139
Nonadherence with INR monitoring and anticoagulant complications 139
A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism 139
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. 139
Risk of Thromboembolism, Recurrent Hemorrhage, and Death after Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding 139
Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry 138
Venous thromboembolism and arterial thromboembolism. Many similarities, far beyond thrombosis per se. 137
Natural anticoagulants deficiency and the risk of venous thromboembolism: A meta-analysis of observational studies 137
Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study. 135
JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease. 135
Short-term prognosis of intracranial haemorrhage in patients on oral anticoagulant or antiplatelet drugs 135
The role of the metabolic syndrome in patients with provoked venous thromboembolic events 135
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events. 134
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients 134
Evaluation of right ventricular function in patients with a previous episode of pulmonary embolism using tissue Doppler imaging. 133
Statins, fibrates, and venous thromboembolism: a meta-analysis. 132
Acquired thrombophilia during pregnancy. 132
Totale 15.913
Categoria #
all - tutte 142.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.143 0 0 0 0 0 0 0 0 39 473 1.012 1.619
2019/20208.877 404 394 476 1.754 653 965 1.231 1.043 721 571 169 496
2020/20217.056 145 653 766 695 409 732 291 619 838 458 574 876
2021/20224.033 403 544 187 104 219 172 325 215 229 726 411 498
2022/20234.541 481 207 319 379 303 958 51 609 661 276 166 131
2023/20248.149 1.244 1.318 1.306 1.603 1.715 562 57 105 239 0 0 0
Totale 41.084